Corteva Catalyst
VC Fund
Corteva Catalyst is a VC fund focused on Biotechnology and Agriculture. Corteva Agriscience's investment and cooperation platform, Corteva Catalyst, is to access and commercialize the newest agricultural innovations that support Corteva's R&D priorities and generate value for our partners, farmers, and business.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Corteva Catalyst invests in
Stages Corteva Catalyst invests in
Countries Corteva Catalyst invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $1.4M–$20M
Investment Focus
Industry
- Biotechnology 7 (88%)
- Agriculture 6 (75%)
- AgTech 3 (38%)
- Farming 2 (25%)
- Organic 1 (13%)
Stage
- Series A 5 (63%)
- Seed 2 (25%)
- Series C 1 (13%)
Country
- United States 2 (25%)
- United Kingdom 2 (25%)
- Brazil 1 (13%)
- Israel 1 (13%)
- Belgium 1 (13%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Chuck Magro
CEO
|
CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Upstream Biotechnology
|
Upstream Biotechnology develops broad-spectrum disease resistant crops using patented technologies to eliminate pesticide use, lower production costs, and boost agricultural yield. | Seed / Jul 30, 2026 | |
Rainbow Crops
|
Rainbow Crops is a next-generation Agtech company developing climate-resilient, high-performing crop varieties. | $11.2M / Seed / Jun 16, 2026 | |
Tropic Biosciences UK Ltd.
|
At Tropic Biosciences, They develop high-performing commercial varieties of tropical crops which promote grower wellbeing, consumer health, and improved sustainable environmental practices, using cutting edge non-GMO gene editing techniques. | $105M / Series C / Mar 12, 2026 | |
Resurrect Bio
|
Resurrect Bio is a plant biotechnology company that will improve the immune systems of crop species to revolutionize the agricultural industry. | $10.3M / Series A / Feb 17, 2026 | |
IBI-Ag
|
IBI-Ag is a biotechnology company developing a new class of bioinsecticides. IBI-Ag is focused on the discovery and development of new types of biological solutions that utilize environmentally friendly technology to control insects. IBI-Ag utilizes breakthrough technology to produce efficient, selective, and safe bio-insect control solutions.IBI-Ag technology is highly cost-effective due to its fermentation suitability enabling farmers to produce agricultural produce at a low cost. | $3.9M / Series A / Nov 11, 2025 | |
Ascribe Bioscience
|
Ascribe Bioscience develops products that enable farmers to combat crop pathogens without negative impacts on the environment. The company is currently developing a seed treatment product that acts by boosting crops’ natural defenses. Ascribe Bioscience was founded in 2017 and is headquartered in Ithaca, New York. | $12M / Series A / Oct 14, 2025 | |
Symbiomics
|
Symbiomics provides the next-generation biologicals based on robust-colonizing microbes for plant growth improvement through sequencing technologies, machine learning, and genome editing tools. | $1.4M / Series A / Jun 25, 2025 | |
Puna Bio
|
Puna Bio develops biological inputs for agriculture that increase yields, reduce carbon emissions, and restore degraded soil. | $20.3M / Series A / Apr 22, 2025 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Corteva Catalyst invest in?
Corteva Catalyst invests primarily in Biotechnology, Agriculture and AgTech startups, most often at Series A and Seed stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Corteva Catalyst's check size?
Corteva Catalyst typically joins rounds of $1.4M–$20M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Corteva Catalyst participates in.
How do I contact Corteva Catalyst?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Corteva Catalyst?
The team at Corteva Catalyst includes Chuck Magro (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
